BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17994490)

  • 1. Evaluation of the Drug Evaluation and Classification program: a critical review of the evidence.
    Beirness DJ; LeCavalier J; Singhal D
    Traffic Inj Prev; 2007 Dec; 8(4):368-76. PubMed ID: 17994490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a more parsimonious approach to drug recognition expert evaluations.
    Porath-Waller AJ; Beirness DJ; Beasley EE
    Traffic Inj Prev; 2009 Dec; 10(6):513-8. PubMed ID: 19916120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair drug testing in the new Brazilian regulation to obtain professional driver's licence: no parallel to any other law enforcement in the world.
    Leyton V; Andreuccetti G; de Almeida RM; Muñoz DR; Walls HC; Greve JM; da Costa Montal JH; Adura FE; Yonamine M
    Addiction; 2015 Jul; 110(7):1207-8. PubMed ID: 25967396
    [No Abstract]   [Full Text] [Related]  

  • 5. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.
    Jones AW
    Traffic Inj Prev; 2005 Dec; 6(4):317-22. PubMed ID: 16266940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplifying the process for identifying drug combinations by drug recognition experts.
    Porath-Waller AJ; Beirness DJ
    Traffic Inj Prev; 2010 Oct; 11(5):453-9. PubMed ID: 20872299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canada's new drug-impaired driving law: the need to consider other approaches.
    Solomon R; Chamberlain E
    Traffic Inj Prev; 2014; 15(7):685-93. PubMed ID: 24380375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of illicit drugs and poly-drug use among drug-impaired drivers in Sweden.
    Holmgren A; Holmgren P; Kugelberg FC; Jones AW; Ahlner J
    Traffic Inj Prev; 2007 Dec; 8(4):361-7. PubMed ID: 17994489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of drivers testing positive for heroin or ecstasy in Norway.
    Hausken AM; Skurtveit S; Christophersen AS
    Traffic Inj Prev; 2004 Jun; 5(2):107-11. PubMed ID: 15203944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling drug detection and diagnosis with the 'drug evaluation and classification program'.
    Schechtman E; Shinar D
    Accid Anal Prev; 2005 Sep; 37(5):852-61. PubMed ID: 15935319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs and driving: the Finnish perspective.
    Lillsunde P; Gunnar T
    Bull Narc; 2005; 57(1-2):213-29. PubMed ID: 21338023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs.
    Hausken AM; Skurtveit S; Christophersen AS
    Drug Alcohol Depend; 2005 Sep; 79(3):423-9. PubMed ID: 16102382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of the validity of the standardized field sobriety test in detecting drug impairment using data from the Drug Evaluation and Classification program.
    Porath-Waller AJ; Beirness DJ
    Traffic Inj Prev; 2014; 15(2):125-31. PubMed ID: 24345013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of drugs and pharmaceuticals in suspected drivers].
    Joó S
    Blutalkohol; 1995 Mar; 32(2):84-91. PubMed ID: 7748526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing reckless drivers for cocaine and marijuana.
    Brookoff D; Cook CS; Williams C; Mann CS
    N Engl J Med; 1994 Aug; 331(8):518-22. PubMed ID: 8041419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use as a predictor of driving under the influence (DUI) rearrests. a 15-year retrospective study.
    Impinen A; Rahkonen O; Karjalainen K; Lintonen T; Lillsunde P; Ostamo A
    Traffic Inj Prev; 2009 Jun; 10(3):220-6. PubMed ID: 19452362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
    Biermann T; Schwarze B; Zedler B; Betz P
    Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Police patrols for alcohol-related crashes: more rigorous evaluation needed.
    Ivers R; Aeron-Thomas A
    Inj Prev; 2008 Dec; 14(6):408-9. PubMed ID: 19074249
    [No Abstract]   [Full Text] [Related]  

  • 20. Hair analysis for drugs in driver's license regranting. A Swedish pilot study.
    Kronstrand R; Nyström I; Forsman M; Käll K
    Forensic Sci Int; 2010 Mar; 196(1-3):55-8. PubMed ID: 20060247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.